InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: macnqueso post# 6100

Sunday, 02/23/2014 11:46:19 AM

Sunday, February 23, 2014 11:46:19 AM

Post# of 55001
In the end any e-cig "solution" will be regulated and taxed as hard as traditional tobacco products...so no market advantage to PM...

In fact how long will it take for FDA to "study" this new product, while curtailing its marketing efforts. It is going to take FDA 4 years to study XXII VLN...not for whether it is VLN, but as to how it can be used in smoke cessation through use of various levels of VLN cigs.

IMHO..no threat...especially if XXII product is "out of the bag" and on the market...before 2015...first mover advantage. If smokers are satisfied with XXII's VLN and VLT cigs as a better health alternative...why would they switch to a "faux" cigarette doing the same thing?

It might be even prove to be an opportunity, since the more emphasis on "safer" cig products...the more XXII technology becomes compelling and is indirectly marketed by all the publicity and emphasis on moving toward the "safe" cig/tobacco products.

And Tommy is right...as soon as MSL acceptance is announced XXII is effectively on the block...when VLN/VLT designation is permitted by FDA, IMHO...XXII will be gobbled up by the most obvious suitor...BT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News